- CEO
- Zhi Hui Zhang
- Full Time Employees
- 592
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- East side of Yongtong Avenue Nantong JS China 226400
- IPO Date
- Dec 13, 2018
- Business
- Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) develops, produces, and sells medical devices focused on anesthesia and analgesia, chronic pain management, and nasal airway care; its principal products include microcomputer fully automatic infusion pumps, disposable infusion pumps, portable electric infusion pumps, wireless analgesia management systems, pulse oximeters, new generation anesthesia depth monitors, internal heat needle therapy devices, low-frequency treatment devices, shock wave therapy devices, physiological seawater nasal sprays, hypertonic buffered seawater nasal care sprayers, weak acid buffered physiological seawater nasal sprays, fixed snore stoppers, and seawater for upper respiratory tract indications. Founded in October 2001 and headquartered in Nantong, Jiangsu Province, China, the company operates primarily in the Chinese market through over 10 subsidiaries in locations including Shanghai, Shenzhen, Hangzhou, Sichuan Province, and Hunan Province, employing over 600 people; it listed on the Shenzhen Stock Exchange GEM board in December 2018. Recent developments include selection as a national-level "little giant" enterprise in January 2023, recognition as an "Advanced Smart Factory in Jiangsu Province" in 2025, launch of the new generation anesthesia depth monitor in early 2023, and acquisitions such as Shenzhen BSK Medical Equipment Co., Ltd. in April 2022 to expand into chronic pain management and Sichuan Jinjiazheng Medical Instrument Co., Ltd. in November 2022 to enter anesthesia depth monitoring.